廠商合計合併營收之變化:2020年5~7月國內上市櫃DRAM製造業者合併營收月增率呈現連續三個月負數態勢，反映先前DRAM下游客戶提前拉貨、DRAM供給釋出的轉疲狀況，換句話說，2020年以來下游客戶對於DRAM的拉貨動能已逐步告一段落，加上疫情所形成的遠端上班、線上教學等對於資料中心、伺服器、NB的需求略顯減緩，況且先前DRAM業者將產能移至CIS的部分又移回，因而使得2020年第二季~第三季DRAM價格走勢已明顯未如原先預期。

A menstrual cup is a feminine hygiene product that are used during menstruation. It is inserted into the vagina and one can keep it inside for maximum 12 hours. Its purpose is to prevent menstrual blood from leaking onto the clothes. It is made up of either latex, silicone, or thermoplastic elastomer. Silicon and thermoplastic elastomer are hypoallergic which means that the wearer can be safe from unwanted irritation and allergies. The menstrual cups are available in a smaller and a larger size, where smaller size is recommended for women under 30 (who have not given birth vaginally) and the larger size is recommended for women who are over 30 (have given birth vaginally or have a heavy flow). The scope of the study is intended to discuss the upcoming and present market trends of menstrual cup. The study provides the revenue generated by the sales of menstrual cups that are used to manage menstruation. It does not include the sales of other feminine hygiene products such as sanitary napkins and tampons. In addition, this report details current market trends, drivers, restraints, and opportunities and determines the future growth potential of the global menstrual cup products market.

The report covers the detailed analysis of the trends, future estimations, and a thorough study of the global mosquito repellent market on the basis of type and distribution channel. It analyses government regulations, policies, and patents to provide information on the current market trends and suggests future growth opportunities. This in turn increases consumer acceptance globally. The study highlights Porter’s five forces analysis to determine the factors affecting the market growth. These factors include raw material prices, intense competition, end users, manufacturers, and suppliers. To understand the market, drivers, restraints, and opportunities are explained in the report. Furthermore, it includes the revenue generated from the sales of footwear across North America, Europe, Asia-Pacific, and LAMEA.

The report provides dynamics, estimations, trends, and forecast related to the global negative pressure wound therapy (NPWT) devices market. This report estimates revenue of a company generated from the direct sales of NPWT devices. However, it does not include the revenue generated by dealers, traders, or brokers involved in the supply of these products to hospitals or clinics for wound treatment. Furthermore, revenue generated from the consulting services provided by doctors at hospitals and clinics is excluded from the report. NPWT devices generate sub-atmospheric pressure to heal acute & chronic wounds and promote recovery of second- and third-degree burns. Two types of devices, namely, V.A.C. ULTA Therapy System marketed by 3M (Acelity L.P. Inc.), RENASYS system marketed by Smith & Nephew plc, are majorly used for healing wounds such as ulcers, burns, and surgical wounds. The negative pressure wound therapy devices market is segmented into product, wound type, end user, and region. On the basis of product, it is classified into conventional NPWT devices and single use disposable NPWT devices. Thus, the report contains the estimations of revenue generated from these two types of devices in the market. The market is divided in these two types of devices to provide a better understanding about the type of NPWT devices that are significantly growing in the market. Furthermore, on the basis of wound type, the market is bifurcated into chronic and acute wounds. This segmentation provides an idea about the use of NPWT devices in the market. Similarly, on the basis of end user, it is divided into hospitals & clinics, ambulatory surgical centers (ASCs), and home care settings.

A skin barrier film is designed to manage fecal inconsistence in bedridden patients, and has proven to be effective even in prevention & infection control. It provides safer patient outcomes and augment ease of nursing. The devices help in attachment of ostomy bags to the individual’s body to maintain incontinence. The scope of the market includes revenue generated by different shapes of skin barrier devices and various surgeries carried with the help of these devices. However, revenue generated from diagnosis of disease and doctor's consultation fees are excluded from the report.

The macular degeneration treatment market is largely driven by rise in the incidence of retinal disorders and growing geriatric population across the world. The aging population is more likely to witness par tial loss of vision, abnormality where straight lines appear wavy, blurred vision, distorted vision, inability to witness in dim light, or spots and other macular degeneration disorders associated with pain. Between 25% and 50% of the community-dwelling elderly have been witnessing several retinal problems since the past few years. According to the data published in the European Society of Retina Specialists (EURETINA), currently, in Europe, an estimated number of 33.6 million persons over the age of 60 years are suffering from AMD. The increasing number of individuals suffering from retinal disorders is directly proportional to the market’s growth. This high prevalence rate denotes the importance of AMD treatment, primarily for treating the target disease. Furthermore, the increasing R&D investments and rising approvals for new drugs of the treatment are other major factors driving the market’s growth. Furthermore, numerous pharmaceutical manufacturers associated with the AMD market, particularly in emerging markets, such India, Brazil, and other nations witnessed significant growth and capitalized over the past decade.

The report provides market dynamics and trends related to the global meningococcal vaccines market. In addition, it presents the estimations and forecast of the market. The estimation includes revenue generated by the revenue generated through sales of meningococcal vaccines, which are used for immunization against different serotypes. Along with sales revenue, demand and supply for meningococcal vaccines across the globe are considered during market estimation. The valuations comprise revenue generated from the sales of the meningococcal vaccines directly from the company. However, it does not include the revenue generated by dealers, traders, or brokers of the market during the supply of these vaccines in hospitals or laboratories. In addition, the report excludes revenue generated from sales of meningococcal vaccine services.

The report provides market dynamics and trends related to the global neurostimulation devices market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from the sales of neurostimulation devices directly from a company and does not include revenue related to neurostimulation services such as doctor fees, consulting, and rehabilitation services. The valuations comprise revenue generated from devices, which are used during neurostimulation therapies. However, the report does not include revenue generated by dealers, traders, or brokers of the market during the supply of these devices in hospitals, clinics, and surgery centers. Furthermore, it excludes revenue generated from post-sale services of devices.

Microarrays are the most popular form of lab-on-a-chip technology, due to the wide range of differentiation and applications. Increasing use of personal medical devices and the need for immediate results fromdiagnostic tests are the major factors driving the demand formicroarrays in the lab-on-a-chip andmicroarraysmarket. The lab-on-a-chip segment of the market studied is expected to have a positive market growth due to the rise in demand for diagnostics, increasing global population, and technological advancement. Furthermore, the rise in the adoption of personalized medicine and easy accessibility of lab-on-a-chip technology are expected to augment the demand for the same across the world. The technological advances have increased the throughput of device production, improved rapid prototyping efforts, and enabled researchers to enhance the complexity and sophistication of experiments that can be performed on a microfluidic chip. As a result,microfluidic technology has its immense potential for research in life science andmedicine. In the United States, the usage of high-throughput screening (HTS) technologies increased drastically in academic research. With the rising interest in HTS, the lab-on-chip technology is expected to be widely used in the country, due to its applications in high-throughput screening.

The market studied is largely driven by the increasing demand in topical analgesics, growth in the geriatric population resulting in the rising prevalence of various diseases, and the cost-efficiency of OTC analgesics drugs. The aged population is more likely to have arthritis, bone and joint disorders, cancer, and other chronic disorders associated with pain. Between 25% and 50% of community-dwelling elderly have several chronic problems. In recent years, the application of OTC analgesics has increased by leaps and bounds, providing great opportunities for improving the management of chronic pain, by improving the efficiency and efficacy of treatment. As per National Institute of Health (NIH), more than 30% of Americans are suffering from chronic pain. Additionally, data from CDC revealed that around 20.4% (50.0 million) of the US adults had chronic pain and 8.0% (19.6 million) had highimpact chronic pain, in 2016. This high prevalence rate denotes the importance of pain management drugs for treating chronic pain.